ORLANDO, Fla., Sept. 10, 2019 /PRNewswire/ -- Rapha Pharma today announced that it has registered Dermatropin Transdermal HGH gel with the US Food and Drug Administration (FDA) and has received a N

ROCKVILLE, Md., Sept. 10, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that J.J. Finkelstein, President and Chief Executive Officer, will present a corporate update at the Fall Investor Su

SAN MATEO, Calif., Sept. 10, 2019 /PRNewswire/ -- CuraSen Therapeutics, Inc., a privately held clinical stage biotechnology company focused on developing therapies to treat neurodegenerative diseases, has appointed Peter Butera as senior vice president, operations. Mr. Butera brings more than 30 years of diverse clinical and operations

GAINESVILLE, Fla., Sept. 10, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealer

VANCOUVER, Sept. 10, 2019 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary United Greeneries Ltd. ("United Greeneries") announces that, on September 6, 2019, it obtained an amendment to its licence from Health Canada which will allow

GENEVA, Sept. 10, 2019 /PRNewswire/ -- Scientis and SENTÉ are entering into an exclusive co-promotion partnership in the United States to provide aesthetics providers and their patients access to Cyspera.

LOS ANGELES and NEW YORK, Sept. 10, 2019 /PRNewswire/ -- Pulsar, the leading healthcare insight and social listening so

LOS ANGELES, Sept. 10, 2019 /PRNewswire/ -- Many remember 9-time Gold Medalist, Mark Spitz, as one of the greatest Olympic athletes of all time. Now Spitz has announced he's been diagnosed with Atrial Fibrillation (AFib) which affects more than 2.7 million Americans and is defined as a quivering or irregular heartbeat that can lea

LINKÖPING, Sweden, Sept. 10, 2019 /PRNewswire/ -- AMRA (www.amramedical.com) has entered into an exclusive agreement with the largest imaging CRO (Contract Research Organization)

SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") announced today that it has entered into a license agreement with Zymeworks Inc. ("ZYMEWORKS") for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support ZYMEWORKS' therapeutic discovery progr